Online citations, reference lists, and bibliographies.
← Back to Search

Preparation And Characterization Of Solid Lipid Nanoparticle-based Nasal Spray Of Budesonide

S. S. Chavan, Subhash G. Ingle, P. Vavia
Published 2012 · Medicine, Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
The present research work was aimed at developing solid lipid nanoparticle (SLN)-based formulation of budesonide (BDS) for nasal delivery. Melt emulsification method was chosen for fabrication of BDS-SLN using ultrasound dispersion and hot high-pressure homogenization techniques. The Compritol888 ATO was chosen as the lipid component for SLN formulation due to highest solubility for BDS. Different surfactants were screened and it was found that combination of Tween 80 and plurol oleique has shown desired particle size with improved stability and entrapment efficiency. The optimized SLN composition had a particle size of 185.2 nm with polydispersibility index of 0.387. Entrapment efficiency of the SLN composition was observed to be 61 %. Further, the optimized SLN dispersion was formulated into nasal spray. In vitro permeation study was carried out using Ovis aries (Indian sheep) nasal mucosa and it was observed that the permeability of BDS nasal spray of SLN was increased significantly by 3.4-fold as compared to the plain BDS and 1.8-fold as compared to the marketed nasal formulation. Thus, SLN-based nasal drug delivery was observed to be a promising approach for improving the bioavailability of hydrophobic drugs.
This paper references
10.1111/j.1572-0241.2007.01380.x
Budesonide in the Treatment of Refractory Celiac Disease
P. Brar (2007)
10.1007/978-3-642-00477-3_4
Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes.
E. Souto (2010)
10.1016/S1466-8564(00)00012-6
Effect of high-pressure homogenization on droplet size distributions and rheological properties of model oil-in-water emulsions
J. Floury (2000)
Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives
Melike Üner (2007)
10.1016/J.JBIOTEC.2004.06.007
Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles.
R. H. Muller (2004)
10.1016/S0169-409X(02)00118-7
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations.
R. Mueller (2002)
10.1080/drd_10_4_245
Preparation and Characterization of Solid Lipid Nanoparticles Containing Cloricromene
M. Bondì (2003)
10.1016/S0939-6411(03)00040-7
The influence of solid lipid nanoparticles on skin hydration and viscoelasticity--in vivo study.
S. Wissing (2003)
10.1023/A:1018992716621
The Bioavailability of Intranasal Salmon Calcitonin in Healthy Volunteers with and Without a Permeation Enhancer
W. Lee (2004)
10.4103/0250-474X.57282
Solid Lipid Nanoparticles: A Modern Formulation Approach in Drug Delivery System
S. Mukherjee (2009)
Drug Deliv. and Transl. Res
(2013)
10.1007/BF00606634
Pharmacokinetics of budesonide in children with asthma
S. Pedersen (2004)
10.1016/S0142-9612(03)00331-4
Physico-chemical stability of colloidal lipid particles.
B. Heurtault (2003)
10.1016/J.IJPHARM.2006.08.007
Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery.
J. Liu (2007)
10.1016/J.IJPHARM.2004.02.032
Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery.
E. Souto (2004)
10.1038/bmt.2008.209
Enteral budesonide in treatment for mild and moderate gastrointestinal chronic GVHD
H. Andree (2008)
10.1016/J.JCONREL.2004.07.030
Transmucosal macromolecular drug delivery.
C. Prego (2005)
10.1016/S0939-6411(97)00150-1
Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism.
A. Zur Mühlen (1998)
10.1016/S0169-409X(97)00069-0
Microspheres as nasal drug delivery systems.
Pereswetoff-Morath (1998)
10.1016/S0939-6411(99)00075-2
Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin.
V. Jenning (2000)
10.1016/S0378-5173(98)00092-1
Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN) dispersions
C. Freitas (1998)
10.1208/s12249-011-9727-6
Duloxetine HCl Lipid Nanoparticles: Preparation, Characterization, and Dosage Form Design
Ketan Patel (2011)
Solid lipid nanoparticles (SLN)--effects of lipid composition on in vitro degradation and in vivo toxicity.
H. Weyhers (2006)
10.1016/j.jconrel.2005.09.052
Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting.
Huabing Chen (2006)
10.1016/J.JCONREL.2005.07.023
Preparation of solid lipid nanoparticles using a membrane contactor.
C. Charcosset (2005)
10.1016/0169-409X(93)90046-7
Nano- and microparticles for the delivery of polypeptides and proteins
P. Couvreur (1993)
Preparation of solid lipid nanoparticles loaded with traditional Chinese medicine by high-pressure homogenization.
Y. Li (2006)
10.1016/S0378-5173(03)00135-2
Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique.
M. Trotta (2003)
10.1080/01932690208984209
Ultrasound Emulsification—An Overview
J. P. Canselier (2002)
Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLNTM) dispersions
C Freitas (1998)
10.1177/0091270003261490
The Pharmacokinetics of Nebulized Nanocrystal Budesonide Suspension in Healthy Volunteers
W. Kraft (2004)
10.1016/S0939-6411(00)00087-4
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
R. Mueller (2000)
10.1080/713817583
Medium scale production of solid lipid nanoparticles (SLN) by high pressure homogenization
V. Jenning (2002)
10.1208/s12249-011-9748-1
Rice Germ Oil as Multifunctional Excipient in Preparation of Self-Microemulsifying Drug Delivery System (SMEDDS) of Tacrolimus
Smita K. Pawar (2011)



This paper is referenced by
10.1080/08982104.2019.1614055
Fabrication, optimization, and in vitro evaluation of docetaxel-loaded nanostructured lipid carriers for improved anticancer activity
Prateek Mathur (2019)
10.1080/03639045.2018.1434194
Process, optimization, and characterization of budesonide-loaded nanostructured lipid carriers for the treatment of inflammatory bowel disease
Gurpreet Kaur Sinhmar (2018)
10.1088/2053-1591/AAF8A3
Fabrication, characterization and optimization of artemether loaded PEGylated solid lipid nanoparticles for the treatment of lung cancer
Hiren N. Khatri (2019)
10.4049/jimmunol.1800658
The Possible Uses and Challenges of Nanomaterials in Mast Cell Research
Brett A Duguay (2020)
10.3109/08982104.2014.954129
Rivastigmine-loaded in situ gelling nanostructured lipid carriers for nose to brain delivery
Preeti Wavikar (2015)
10.3389/fcimb.2020.570573
Recuperating Biopharmaceutical Aspects of Amphotericin B and Paromomycin Using a Chitosan Functionalized Nanocarrier via Oral Route for Enhanced Anti-leishmanial Activity
Shabi Parvez (2020)
10.2174/0929867326666190827151741
Intranasal Nanoparticulate Systems as Alternative Route of Drug Delivery.
Areen Alshweiat (2019)
10.1007/s11051-019-4671-6
Exploring the drug-lipid interaction of weak-hydrophobic drug loaded solid lipid nanoparticles by isothermal titration calorimetry
Zhengwei Huang (2019)
10.1007/978-3-030-34544-0_13
Solid Lipid Nanoparticles
A. Jain (2020)
10.1080/03639045.2018.1506472
Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis
Nimitt V. Chokshi (2018)
10.1016/j.lfs.2016.08.033
Development of risperidone liposomes for brain targeting through intranasal route.
Reema Narayan (2016)
10.2147/IJN.S87148
Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease
Bruno Fonseca-Santos (2015)
10.3390/pharmaceutics10030128
Stealth and Cationic Nanoliposomes as Drug Delivery Systems to Increase Andrographolide BBB Permeability
V. Piazzini (2018)
Semantic Scholar Logo Some data provided by SemanticScholar